Development of a Therapeutic Natural Killer Cell Product Generated from Cord Blood CD34+ Cells Expanded on Notch Ligand
Main Authors: | Carrie Stoltzman, Mary Prieve, Elizabeth Dam, Kevin Haworth, Erin Massey, Joe Blake, Devikha Chandrasekaran, Courtney Crane, Colleen Delaney |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-09-01
|
Series: | Stem Cells Translational Medicine |
Online Access: | https://doi.org/10.1002/sctm.12582 |
Similar Items
-
An Uncoupling of Canonical Phenotypic Markers and Functional Potency of Ex Vivo-Expanded Natural Killer Cells
by: Nicole A. P. Lieberman, et al.
Published: (2018-02-01) -
Using Expanded Natural Killer Cells as Therapy for Invasive Aspergillosis
by: Win Mar Soe, et al.
Published: (2020-10-01) -
Notch signalling in CD34+ cells in chronic myeloid leukaemia
by: Al-Jedai, Abdullah H.
Published: (2008) -
The role of Notch-1 in ex vivo expansion of CD34(+) cells
by: Merchut-Maya, Joanna
Published: (2012) -
Culture-Expanded Human Invariant Natural Killer T Cells Suppress T-Cell Alloreactivity and Eradicate Leukemia
by: Hannes Schmid, et al.
Published: (2018-08-01)